Atlas Trials

Mild Cognitive Impairment, Use of qEEG as a Prognostic Marker

Clinical trial NCT03659643 · UNKNOWN

Trial details

NCT number
NCT03659643
Sponsor
Jon Snaedal
Status
UNKNOWN
Study type
OBSERVATIONAL
Mild Cognitive Impairment
Start date
2018-01-01
Primary completion
2020-10-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.